Nucleophosmin Redistribution following Heat Shock: A Role in Heat-Induced RadiosensitizationVANDERWAAL, Robert P; MAGGI, Leonard B; WEBER, Jason D et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 16, pp 6454-6462, issn 0008-5472, 9 p.Article

Involvement of Regulations of Nucleophosmin and Nucleoporins in Gambogic Acid-Induced Apoptosis in Jurkat CellsWENXIU SHU; YAN CHEN; RUI LI et al.Basic & clinical pharmacology & toxicology (Print). 2008, Vol 103, Num 6, pp 530-537, issn 1742-7835, 8 p.Article

Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomasFALINI, B; LENZE, D; PETTIROSSI, V et al.Leukemia. 2007, Vol 21, Num 7, pp 1566-1570, issn 0887-6924, 5 p.Article

Involvement of nucleophosmin/B23 in TPA-induced megakaryocytic differentiation of K562 cellsHSU, C. Y; YUNG, B. Y. M.British journal of cancer. 2003, Vol 89, Num 7, pp 1320-1326, issn 0007-0920, 7 p.Article

The Novel Chemical Entity YTR107 Inhibits Recruitment of Nucleophosmin to Sites of DNA Damage, Suppressing Repair of DNA Double-Strand Breaks and Enhancing RadiosensitizationSEKHAR, Konjeti R; YERRAMREDDY THIRUPATHI REDDY; SALLENG, Kenneth J et al.Clinical cancer research (Print). 2011, Vol 17, Num 20, pp 6490-6499, issn 1078-0432, 10 p.Article

Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia : impact on WHO classification. CommentaryGRIMWADE, David; PASQUALUCCI, Laura; MANNUCCI, Roberta et al.Blood. 2006, Vol 108, Num 13, issn 0006-4971, 3965,4146-4155 [11 p.]Article

Tumor Suppressor HLJ1 Binds and Functionally Alters Nucleophosmin via Activating Enhancer Binding Protein 2α Complex FormationCHANG, Tzu-Pei; YU, Sung-Liang; LIN, Sheng-Yi et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 4, pp 1656-1667, issn 0008-5472, 12 p.Article

Ubiquitination and proteasomal degradation of nucleophosmin-anaplastic lymphoma kinase induced by 17-allylamino-demethoxygeldanamycin: Role of the co-chaperone carboxyl heat shock protein 70-interacting proteinBONVINI, Paolo; DALLA ROSA, Henry; VIGNES, Nadia et al.Cancer research (Baltimore). 2004, Vol 64, Num 9, pp 3256-3264, issn 0008-5472, 9 p.Article

Is the Association of Cup-like Nuclei With Mutation of the NPM1 Gene in Acute Myeloid Leukemia Clinically Useful?BENNETT, John M; PRYOR, Jennifer; LAUGHLIN, Todd S et al.American journal of clinical pathology. 2010, Vol 134, Num 4, pp 648-652, issn 0002-9173, 5 p.Article

A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1)LISO, Arcangelo; CASTIGLIONE, Filippo; MARTELLI, Massimo F et al.Haematologica (Roma). 2008, Vol 93, Num 8, pp 1219-1226, issn 0390-6078, 8 p.Article

Increased expression of nucleophosmin/B23 in hepatocellular carcinoma and correlation with clinicopathological parametersYUN, J.-P; MIAO, J; CHEN, G. G et al.British journal of cancer. 2007, Vol 96, Num 3, pp 477-484, issn 0007-0920, 8 p.Article

Nucleophosmin as a Candidate Prognostic Biomarker of Ewing's Sarcoma Revealed by ProteomicsKIKUTA, Kazutaka; TOCHIGI, Naobumi; KONDO, Tadashi et al.Clinical cancer research (Print). 2009, Vol 15, Num 8, pp 2885-2894, issn 1078-0432, 10 p.Article

Ribosome-associated nucleophosmin 1: increased expression and shuttling activity distinguishes prognostic subtypes in chronic lymphocytic leukaemiaREES-UNWIN, Karen S; FARAGHER, Robin; BANHAM, Alison H et al.British journal of haematology. 2010, Vol 148, Num 4, pp 534-543, issn 0007-1048, 10 p.Article

Nucleophosmin suppresses oncogene-induced apoptosis and senescence and enhances oncogenic cooperation in cells with genomic instabilityJUNE LI; SEJAS, Daniel P; BURMA, Sandeep et al.Carcinogenesis (New York. Print). 2007, Vol 28, Num 6, pp 1163-1170, issn 0143-3334, 8 p.Article

Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity?FALINI, Brunangelo; PAOLA MARTELLI, Maria; BOLLI, Niccolò et al.Blood. 2011, Vol 117, Num 4, pp 1109-1120, issn 0006-4971, 12 p.Article

DNA damage disrupts the p14ARF-B23(nucleophosmin) interaction and triggers a transient subnuclear redistribution of p14ARFLEE, Casey; SMITH, Brian A; BANDYOPADHYAY, Keya et al.Cancer research (Baltimore). 2005, Vol 65, Num 21, pp 9834-9842, issn 0008-5472, 9 p.Article

Nucleophosmin mutations in childhood acute myelogenous leukemia with normal karyotypeCAZZANIGA, Giovanni; GRAZIA DELL'ORO, Maria; BIONDI, Andrea et al.Blood. 2005, Vol 106, Num 4, pp 1419-1422, issn 0006-4971, 4 p.Article

Acute myeloid leukemia with mutated nucleophosmin (NPM1): Any hope for a targeted therapy?FALINI, Brunangelo; GIONFRIDDO, Ilaria; CECCHETTI, Federica et al.Blood reviews. 2011, Vol 25, Num 6, pp 247-254, issn 0268-960X, 8 p.Article

A monoclonal antibody against mutated nucleophosmin 1 for the molecular diagnosis of acute myeloid leukemiasGRUSZKA, Alicja M; LAVORGNA, Serena; CEDRONE, Michele et al.Blood. 2010, Vol 116, Num 12, pp 2096-2102, issn 0006-4971, 7 p.Article

Minimal residual disease-directed preemptive treatment with azacitidine in patients with NPM1-mutant acute myeloid leukemia and molecular relapseSOCKEL, Katja; WERMKE, Martin; RADKE, Jörgen et al.Haematologica (Roma). 2011, Vol 96, Num 10, pp 1568-1570, issn 0390-6078, 3 p.Article

Cytoplasmic Expression of Nucleophosmin Accurately Predicts Mutation in the Nucleophosmin Gene in Patients With Acute Myeloid Leukemia and Normal KaryotypeLUO, Jennifer; CONNIE QI; WEI XU et al.American journal of clinical pathology. 2010, Vol 133, Num 1, pp 34-40, issn 0002-9173, 7 p.Article

Clinical implications of minimal residual disease monitoring by quantitative polymerase chain reaction in acute myeloid leukemia patients bearing nucleophosmin (NPM1) mutationsCHOU, W.-C; TANG, J.-L; WU, S.-J et al.Leukemia. 2007, Vol 21, Num 5, pp 998-1004, issn 0887-6924, 7 p.Article

Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implicationsFALINI, B; BOLLI, N; LISO, A et al.Leukemia. 2009, Vol 23, Num 10, pp 1731-1743, issn 0887-6924, 13 p.Article

Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98BSCHLENK, Richard F; DÖHNER, Konstanze; HABDANK, Marianne et al.Haematologica (Roma). 2009, Vol 94, Num 1, pp 54-60, issn 0390-6078, 7 p.Article

Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutationsGORELLO, P; CAZZANIGA, G; LO COCO, F et al.Leukemia. 2006, Vol 20, Num 6, pp 1103-1108, issn 0887-6924, 6 p.Article